Title
Author
DOI
Article Type
Special Issue
Volume
Issue
European Journal of Gynaecological Oncology (EJGO) is published by MRE Press from Volume 43 Issue 3 (2022). Previous articles were published by another publisher, and they are hosted by MRE Press on www.ejgo.net as a courtesy and upon agreement with European Journal of Gynaecological Oncology.
Prediction of cervical infiltration in Stage II endometrial cancer by different preoperative evaluation techniques (D&C, US, CT, MRI)
1Gynecology Dept., Hungary
2Dept. of Radiodiagnostics, Hungary
3Dept. of Pathology and Exp. Cancer Research, National Institute of Oncology, Budapest, Hungary
4Semmelweis University, Faculty of Medicine, Budapest, Hungary
*Corresponding Author(s): I. Pete E-mail:
Objective: Our clinical practice for FIGO Stage II endometrial cancer consists of Wertheim's radical hysterectomy as first choice of treatment. The evaluation of patients is based on D&C. The accuracy of this preoperative staging method is examined here.
Methods: Twenty-nine patients with endometrial cancer with suspected cervical involvement (FIGO Stage II) based on endocervical curettage underwent Wertheim's radical hysterectomy between January 1, 1989 and December 31, 2001 at the Gynaecological Department of the National Institute of Cancer, Budapest, Hungary. In all cases surgico-pathological staging was performed to examine the accuracy of preoperative D&C and to find out whether radical surgery was necessary in all patients and how the preoperative evaluation of patients should be improved.
Results: Out of 29 patients who underwent Wertheim's hysterectomy the pathological examination found primary cervical cancer in two patients. These two patients were eliminated from further evaluation. Out of the remaining 27 patients only eight (29.6%) had cervical involvement of endometrial cancer documented by a pathologic review on the hysterectomy specimen. Extrauterine disease was documented in one of the patients with cervical infiltration (1/8) and in one in the cervix-negative group (1/19). Ovarian spread was found in the first case and ovarian infiltration with penetration of the tumour into the parametric tissue in the second case. According to the FIGO classification 18 (66.6%) patients had less extensive disease and two (7.4%) had more extensive disease. Only 26% of the patients (7/27) had surgical findings consistent with the Stage II disease.
Conclusion: We can conclude that "overtreatment" seems to have occurred in 19 patients, whose cervical infiltration by endometrial cancer could not be proved by pathological staging. It can also be assessed that understaging took place in two cases, which can be explained by two reasons; we did not make use of preoperative imaging techniques since US was applied in six patients, CT in 16 and the most accurate, MRI, on three patients only. The other possible reason, which can point out the bad efficacy of the imaging techniques as well, could be that a major part of the patients received preoperative AL treatment, which could also have influenced the cervical progression. This is possible, but has not been proved. The difference in the number of cervical infiltrations in the group of patients who received preoperative radiotherapy and in the group where they did not, is not significant (p = 0.9742), and infiltration of the endometrium was present in all cases. In the future, proper selection of imaging modalities can improve the staging of gynaecological disorders and preclude unnecessary procedures. In endometrial cancer cases US, especially with the use of TVUS, is often considered to be the primary imaging approach. However, in patients where ultrasound is suboptimal, where there is a large tumour present or the result of imaging studies will directly influence the choice of therapy and guide therapy planning then the higher accuracy of MRI warrants its use. CT is of use in the later stages of disease; differentiation between Stage I and II is difficult and CT is limited in the assessment of myometrial invasion.
Stage II endometrial cancer; D&C; Patient evaluation; Wertheim's hysterectomy; US, TYUS, CT, MRI
I. Pete, M. Godeny, E. Tóth, J. Radó, B. Pete, T. Pulay. Prediction of cervical infiltration in Stage II endometrial cancer by different preoperative evaluation techniques (D&C, US, CT, MRI). European Journal of Gynaecological Oncology. 2003. 24(6);517-522.
[1] Barnes M.N., Kilgone L.C.: "Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes". Sem. Radial. Oneal., 2000, 10, 3.
[2] Bruckman J.E., Goodman R.L., Murthy A., Marek A.: "Combined irradiation and surgery in the treatment of Stage II carcinoma of the endometrium". Cancer, 1978, 42, 1146.
[3] Cacciatore B., Lehtivirta P., Wahlstrom T., Yliinen B., Y liistalo P.: "Contribution of vaginal scanning to sonographic evaluation of endometrial cancer invasion". Acta Oneal., 1989, 28, 585.
[4] Creasman W.T., Morrow C.P., Bundy L.: "Surgical pathological spread patterns of endometrial cancer". Cancer, 1987, 60, 2035.
[5] Del Maschio A., Vanzulli A., Sironi S., Spagnolo D., Belloni C., Garancini P., Taccagni G.L.: "Estimating the depth of myometrial involvement by endometrial carcinoma: efficacy of transvaginal sonography vs MR imaging". Am. J. Reprod., 1993, 160, 533.
[6] Dore R., Moro V., D'Andrea F., La Fianza A., Franchi M., Bolis P.F.: "CT evaluation of myometrial invasion in eudometrial carcinoma". JCAT, 1987, 11, 282.
[7] FIGO news: "Corpus cancer staging". Int. J. Gynecol. Obstet., 1989, 28, 190.
[8] Fleisher AC., Rodgers W.H., Kepple D.M., Williams L.L., Jones H.W.: "Color Doppler sonography of ovarian masses: multiparameter analysis". Ultrasound Med., 1993, 12, 41.
[9] Fletcher G.H.: "Clinical dose-response curves of human malignant epithelial tumors". Br. J. Radio/., 1973, 46, 1.
[10] Gordon AN., Fleischer A.C., Dudley B.S.: "Preoperative assessment of myometrial invasion of endometrial adenocarcinoma by sonography (US) and magnetic resonance imaging". Gynecol Oncol., 1989, 34, 175.
[11] Greco P., Cormio G., Vimarcati A., Loverro G., Selvaggi L.:"Transvaginal color Doppler sonography in predicting the response to chemotherapy in advanced cervical cancer". Ultrasound Obstet. Gynecol., 1997, 9, 49.
[12] Hamm B., Kubin-Huch R.A., Fleige B.: "MR imaging and CT of the female pelvis: radiologic-pathologic correlation". Eur. Radiol., 1999, 9, 3.
[13] Heller D.S., Drosinos S., Westhoff C.: "Accuracy of tumor grade assigned at initial endometrial sampling (letter)". Int. J. Gynaecol. Obstet., 1997, 47, 301.
[14] Hirai Y., Kaku S., Teshima H. et al.: "Use of angio computed tomography to evaluate extent of endometrial carcinoma". Gynecol. Oncol., 1989, 33, 372.
[15] Hricak H.. Rubinstein L., Gherman G.M., Karstaedt N.: "MR imaging evaluation of endometrial carcinoma: Results of an NCI cooperative study". Radiology, 1991a, 179, 829.
[16] Hricak H., Hamm B., Semelka R.C., Cann C.E., Nauerl T., Secaf E. et al.: "Carcinoma of the uterus: use of gadopentetate dimeglumine in MR imaging". Radiology, 1991b, 181 (1), 95.
[17] Hricak H.:''Cancer of the uterus: The value of MR 1magmg in pimary and recurrent diseaseand its potential impact on patient management". Dissertation, May 7, Stockholm, Sweden, 1992.
[18] Hricak H.: "MR imaging in gynecologic oncology". Eur. Radiol., 1993, 3, 2.
[19] Hsieh C.Y., Wu C.C., Chen C.A., Chen T.M., Chen C.A., Chen C.L. et al.: "Clinical significance of intratumoral blood flow in cervical carcinoma assessed by color Doppler ultrasound". Cancer, 1995, 19, 2518.
[20] Kadar N., Malfateno J.H., Homesley H.D.: "Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy" Ohstet. Gynecol., 1992, 80, 655.
[21] Kim S.H.,Kim H.D.,S ong Y.S.,K ang S.B.,L ee H.P.: "Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound,C T,a nd MRI". JCAT, 1995,19, 766.
[22] Kottmeier H.L.: "Classification and clinical staging of carcinoma of the uterus and vagina". J. Int. Fed. Gynecol. Obstet., 1971, 9, 172.
[23] Kucera E., Kainz Ch., Reinthaller A., Sliutz G., Leodolter S., Kucera H., Breitenecker G.: "Accuracy of intraoperative frozensection diadnosis in stage I endometrial carcinoma". Gynecol. Obstet. Invest., 2000, 49, 62.
[24] Lien H.H.,B lomlie V.,T rope C.,K aern J.,A beler V.M.: "Cancer of the endometrium: Value of MR imaging in determining depth of invasion into the myometrium". Arn. J. Reprod., 1991, 157, 1221.
[25] Longarce TA., Kempson R.L., Hendrickson M.R.: "Endometrial hyperplasia, metaplasia and carcinoma". In: Obstetrical and Gynaecological Pathology, H. Fox (ed.), Churchill Livingston 1995, 421.
[26] Mannel R.S., Berman M.L.. Walker J.L., Manetta A., DiSaia P.J.: "Management of endometrial cancer with suspected cervical involvement". Obstet. Gynecol., 1990, 75, 1016.
[27] Mariani A., Webb M.J., Keeney G.L., Haddock M.G., Calori G., Podratz K.C.: "Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessery?". Am. J. Obstet. Gynecol., 2000,182, 1506.
[28] Mikuta J.J.: "Preoperative evaluation and staging of endometrial cancer". Cancer, 1995, 76, 2041.
[29] Szantho A., Szabo I., Csapo Zs., Belega J., Demeter A., Papp Z.: "Assessment of myometrial and cervical invasion of endometrial cancer by transvaginal sonography". Eur. J. Gynaecol. Oncol., 2001, 22 (3), 209.
[30] Takahashi S., Murakami T., Narumi Y. et al.: "Preoperative stagmg of endometrial carcinoma: diagnostic effect of T2-weighted fast spin-echo MR imaging". Radiology, 1998, 206, 589.
[31] Thorvinger B., Gudmundsson T., Horvath G., Forsberg L., Holtas S.: "Staging in local endometrial carcinoma: Assessment of magnetic resonance and ultrasound examination". Acta Radiol., 1989, 30, 252.
[32] Trimble E.L., Jones H.W.: "Management of Stage II endometrial cancer". Obstet. Gynecol., 1988, 71, 323.
[33] Wallin T.E., Malkasian G.D. Jr., Gaffey T.A., O'Brien P.C., Fountain K.S.: "Stage JI cancer of the endometrium: A pathological and clinical study". Gynecol. Oncol.,1984, 18, 1.
[34] Yamashita Y., Mizutani H., Torashima M., Takahasi M., Miyazaki K., Okamura H. et al.: "Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrastenhanced MR imaging". Am. J. Reprod., 1993, 161,595
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.
Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.
JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.
Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.
BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Top